Granulomatosis with polyangiitis: Difference between revisions
Line 42: | Line 42: | ||
== Diagnosis == | == Diagnosis == | ||
[[Wegener's granulomatosis diagnostic criteria|Diagnostic Criteria]] | [[Wegener's granulomatosis history and symptoms| History and Symptoms]] | [[Wegener's granulomatosis physical examination | Physical Examination]] | [[Wegener's granulomatosis laboratory findings| Laboratory Findings]] | [[Wegener's granulomatosis chest | [[Wegener's granulomatosis diagnostic criteria|Diagnostic Criteria]] | [[Wegener's granulomatosis history and symptoms| History and Symptoms]] | [[Wegener's granulomatosis physical examination | Physical Examination]] | [[Wegener's granulomatosis laboratory findings| Laboratory Findings]] | [[Wegener's granulomatosis chest x ray|Chest X Ray]] | [[Wegener's granulomatosis CT|CT]] | [[Wegener's granulomatosis other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== |
Revision as of 19:16, 28 September 2012
Template:DiseaseDisorder infobox
Granulomatosis with polyangiitis Microchapters |
Differentiating Granulomatosis with polyangiitis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Granulomatosis with polyangiitis On the Web |
American Roentgen Ray Society Images of Granulomatosis with polyangiitis |
Directions to Hospitals Treating Granulomatosis with polyangiitis |
Risk calculators and risk factors for Granulomatosis with polyangiitis |
For patient information click here
Click here for The heart in Wegener's granulomatosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Wegener's granulomatosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies